Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 18 studies | 27% ± 11% | |
macrophage | 18 studies | 28% ± 15% | |
astrocyte | 12 studies | 38% ± 17% | |
fibroblast | 12 studies | 23% ± 6% | |
glutamatergic neuron | 10 studies | 47% ± 22% | |
microglial cell | 10 studies | 28% ± 14% | |
oligodendrocyte precursor cell | 9 studies | 28% ± 13% | |
GABAergic neuron | 8 studies | 45% ± 22% | |
amacrine cell | 7 studies | 32% ± 11% | |
retinal cone cell | 7 studies | 55% ± 17% | |
retinal rod cell | 7 studies | 33% ± 11% | |
monocyte | 7 studies | 26% ± 6% | |
natural killer cell | 7 studies | 18% ± 3% | |
pericyte | 7 studies | 23% ± 10% | |
myeloid cell | 6 studies | 28% ± 7% | |
epithelial cell | 6 studies | 34% ± 14% | |
ciliated cell | 6 studies | 25% ± 6% | |
dendritic cell | 6 studies | 25% ± 5% | |
type I pneumocyte | 6 studies | 21% ± 6% | |
smooth muscle cell | 6 studies | 20% ± 1% | |
oligodendrocyte | 6 studies | 25% ± 11% | |
retinal bipolar neuron | 5 studies | 68% ± 10% | |
OFF-bipolar cell | 5 studies | 51% ± 19% | |
ON-bipolar cell | 5 studies | 58% ± 17% | |
retinal ganglion cell | 5 studies | 60% ± 20% | |
club cell | 5 studies | 20% ± 6% | |
adipocyte | 5 studies | 19% ± 3% | |
type II pneumocyte | 5 studies | 23% ± 5% | |
classical monocyte | 4 studies | 21% ± 6% | |
non-classical monocyte | 4 studies | 23% ± 8% | |
neuron | 4 studies | 41% ± 10% | |
CD8-positive, alpha-beta T cell | 4 studies | 16% ± 1% | |
basal cell | 4 studies | 30% ± 14% | |
CD4-positive, alpha-beta T cell | 4 studies | 16% ± 1% | |
lymphocyte | 4 studies | 27% ± 11% | |
endothelial cell of lymphatic vessel | 4 studies | 25% ± 9% | |
alveolar macrophage | 4 studies | 34% ± 14% | |
interneuron | 4 studies | 55% ± 22% | |
conventional dendritic cell | 3 studies | 21% ± 4% | |
GABAergic interneuron | 3 studies | 30% ± 5% | |
B cell | 3 studies | 21% ± 4% | |
rod bipolar cell | 3 studies | 91% ± 5% | |
hepatocyte | 3 studies | 41% ± 25% | |
muscle cell | 3 studies | 24% ± 11% | |
ependymal cell | 3 studies | 31% ± 16% | |
T cell | 3 studies | 20% ± 2% | |
granule cell | 3 studies | 28% ± 3% | |
mast cell | 3 studies | 20% ± 5% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 17% ± 1% | |
effector memory CD8-positive, alpha-beta T cell, terminally differentiated | 3 studies | 16% ± 1% | |
renal principal cell | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4596.94 | 1445 / 1445 | 100% | 68.84 | 183 / 183 |
lung | 100% | 4367.21 | 578 / 578 | 100% | 58.27 | 1154 / 1155 |
breast | 100% | 3689.94 | 459 / 459 | 100% | 78.45 | 1114 / 1118 |
thymus | 100% | 4898.74 | 653 / 653 | 99% | 77.67 | 601 / 605 |
ovary | 100% | 3274.27 | 180 / 180 | 99% | 44.56 | 424 / 430 |
kidney | 100% | 2801.13 | 89 / 89 | 98% | 47.19 | 885 / 901 |
intestine | 100% | 4681.10 | 966 / 966 | 98% | 41.32 | 516 / 527 |
stomach | 100% | 3103.20 | 359 / 359 | 98% | 48.01 | 280 / 286 |
prostate | 100% | 3755.60 | 244 / 245 | 98% | 51.27 | 493 / 502 |
brain | 99% | 4755.55 | 2621 / 2642 | 98% | 34.89 | 694 / 705 |
uterus | 100% | 4396.94 | 170 / 170 | 97% | 38.93 | 443 / 459 |
bladder | 100% | 4527.10 | 21 / 21 | 96% | 38.07 | 486 / 504 |
liver | 100% | 3245.25 | 226 / 226 | 95% | 36.33 | 387 / 406 |
pancreas | 97% | 1967.66 | 318 / 328 | 98% | 44.74 | 174 / 178 |
adrenal gland | 100% | 3794.79 | 258 / 258 | 93% | 28.42 | 214 / 230 |
skin | 100% | 5114.32 | 1806 / 1809 | 92% | 35.10 | 433 / 472 |
adipose | 100% | 3965.32 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5907.21 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 5299.31 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3169.37 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 43.46 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.01 | 1 / 1 |
heart | 96% | 2759.14 | 827 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 35.64 | 27 / 29 |
eye | 0% | 0 | 0 / 0 | 73% | 26.97 | 58 / 80 |
peripheral blood | 67% | 2224.10 | 624 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
Gene name | EFR3A |
Protein name | Protein EFR3 homolog A (Protein EFR3-like) EFR3A protein EFR3 homolog A |
Synonyms | KIAA0143 |
Description | FUNCTION: Component of a complex required to localize phosphatidylinositol 4-kinase (PI4K) to the plasma membrane . The complex acts as a regulator of phosphatidylinositol 4-phosphate (PtdIns(4)P) synthesis (Probable). In the complex, EFR3A probably acts as the membrane-anchoring component . Also involved in responsiveness to G-protein-coupled receptors; it is however unclear whether this role is direct or indirect . . |
Accessions | ENST00000522709.5 E5RJS1 ENST00000520362.5 Q14156 ENST00000637848.1 ENST00000254624.10 [Q14156-1] ENST00000519656.1 [Q14156-2] A0PJL1 A2VDI4 A0A1B0GUZ7 E5RFJ2 |